 |
BakerHostsAttorneys across BakerHostetlers practice groups discuss timely legal topics and provide unique insights and analysis. Author: BakerHosts BakerHostetler
The BakerHosts podcast features attorneys across BakerHostetlers practice groups discussing timely legal topics and providing unique insights and analysis. Lively conversations and informative legal analysis when you need it. Language: en Genres: Business Contact email: Get it Feed URL: Get it iTunes ID: Get it |
Listen Now...
Regulatory Horizons: What Life Sciences Companies Should Know About the BIOSECURE Act
Episode 261
Tuesday, 10 March, 2026
Today’s topic is a big one: the BIOSECURE Act, signed into law on December 18, 2025, as part of the FY 2026 National Defense Authorization Act. The law restricts federal agencies, contractors, and grant recipients from procuring or using biotechnology equipment or services from what the statute calls “biotechnology companies of concern.” This is more than a procurement rule—it has broad implications for biopharma, device companies, CDMOs, CROs, genomics companies, and even research institutions relying on federal funds. Implementation timelines, designations, and compliance obligations are already starting to take shape.Questions and Comments: wkirton@bakerlaw.com and ahiggins@bakerlaw.com
